TTX-332

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameTTX-332
Drug Alias NameTTX-332
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear receptor subfamily 4 group A member 1 modulators
TargetsNuclear receptor subfamily 4 group A member 1
Therapy Area/IndicationsDelayed Graft Function
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTemple Therapeutics Bv
China Registration ClassN/A

Develop Information

Active CompaniesTemple Therapeutics Bv
Inactive CompaniesN/A
Active IndicationsDelayed Graft Function
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A